共 50 条
- [21] PRIMARY VERSUS POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) IN PATIENTS WITH PRESENCE OF TERATOMA AT ORCHIECTOMY JOURNAL OF UROLOGY, 2010, 183 (04): : E221 - E221
- [24] Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors JOURNAL OF UROLOGY, 2015, 194 (02): : 386 - 391
- [26] Rates of Teratoma and Viable Cancer at Post-Chemotherapy Retroperitoneal Lymph Node Dissection after Induction Chemotherapy for Good Risk Nonseminomatous Germ Cell Tumors JOURNAL OF UROLOGY, 2015, 193 (02): : 513 - 518
- [28] RATES OF TERATOMA AT POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION BY INDUCTION CHEMOTHERAPY REGIMEN FOR GOOD RISK NON-SEMINOMATOUS GERM CELL TUMORS JOURNAL OF UROLOGY, 2011, 185 (04): : E334 - E334
- [29] COMPLICATIONS OF POSTCHEMOTHERAPY RETROPERITONEAL LYMPH-NODE DISSECTION JOURNAL OF UROLOGY, 1995, 153 (03): : 976 - 980